D. E. Shaw & Co., Inc. Kala Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.3 - $1.31 $8,867 - $38,722	-29,559 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.61 - $1.84 $47,594 - $143,562	-78,023 Reduced 72.52%	29,559 $41,000
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.74 $124,795 - $294,774	107,582 New	107,582 $130,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $176,553 - $284,369	-34,892 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.24 - $9.58 $14,320 - $21,986	2,295 Added 7.04%	34,892 $235,000
Q4 2020 Feb 16, 2021	BUY	$6.28 - $8.79 $45,837 - $64,158	7,299 Added 28.85%	32,597 $221,000
Q3 2020 Nov 16, 2020	SELL	$7.5 - $11.11 $1.1 Million - $1.63 Million	-146,600 Reduced 85.28%	25,298 $190,000
Q2 2020 Aug 14, 2020	BUY	$8.33 - $13.79 $968,637 - $1.6 Million	116,283 Added 209.09%	171,898 $1.81 Million
Q1 2020 May 15, 2020	BUY	$3.83 - $8.79 $213,005 - $488,855	55,615 New	55,615 $489,000
Q2 2019 Aug 14, 2019	SELL	$4.93 - $8.8 $219,754 - $392,260	-44,575 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$5.19 - $8.97 $332,237 - $574,214	-64,015 Reduced 58.95%	44,575 $369,000
Q4 2018 Feb 14, 2019	BUY	$4.29 - $9.94 $372,311 - $862,652	86,786 Added 398.03%	108,590 $531,000
Q3 2018 Nov 14, 2018	BUY	$9.54 - $13.87 $208,010 - $302,421	21,804 New	21,804 $215,000
Q2 2018 Aug 14, 2018	SELL	$13.3 - $17.49 $388,945 - $511,477	-29,244 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$12.26 - $18.98 $358,531 - $555,051	29,244 New	29,244 $463,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.08M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.